Article 22: Authorised Representative for High-Risk Systems
Article 22 requires providers of high-risk AI systems established outside the EU to appoint, by written mandate, an authorised representative established in the EU before making the system available on the EU market. The representative verifies conformity documentation, keeps records available for authorities, and cooperates with market surveillance.
- 02 Dec 2027 Applies to Annex III high-risk systems
- 02 Aug 2028 Applies to Annex I embedded high-risk systems
- Appoint an EU-established authorised representative by written mandate before placing the system on the EU market, if the provider is not established in the EU.
- Ensure the representative can verify that the EU declaration of conformity and technical documentation have been drawn up.
- Keep a copy of the technical documentation available to the representative for provision to authorities on request.
- Cooperate with the representative in responding to requests from competent authorities.
- Written mandate
- Copy of technical documentation held by the representative
The Article 22 authorised representative for high-risk systems is often confused with the separate Article 54 authorised representative required for GPAI models — a company that is both a high-risk provider and a GPAI provider may need two different representatives with different mandates.
What regulators published on Art. 22
- Loading from the public feed…
- Regulation (EU) 2024/1689 on EUR-Lex
- Look for Article 22
- Deadline changes and the acts behind them
Get told when Art. 22 moves.
Deadlines under this regulation have already shifted once in 2026. A signed webhook, a REST API and an MCP server carry the same record this page is built from, so your systems learn about the next change without anyone re-reading the text. Free during the beta.
Get free accessInformational content only. Not legal advice and not a substitute for qualified counsel. Dates reflect Regulation (EU) 2026/1744 as of 04 Aug 2026.